FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3197699016> ?p ?o ?g. }

• W3197699016 endingPage "1121" @default.
• W3197699016 startingPage "1116" @default.
• W3197699016 abstract "Purpose: The efficacy and safety of topical cyclosporine 0.1% in preventing early graft failure after therapeutic penetrating keratoplasty (TPK) in eyes with fungal keratitis were evaluated. Methods: This prospective case series included patients with fungal keratitis undergoing TPK from May to December 2019 who were treated with cyclosporine A 0.1% eye drops (tCSA group). We compared the outcome with a historical cohort of patients who were treated conventionally (CT group) with topical prednisolone acetate 1% eye drops started 3 weeks after surgery. Results: There were 20 patients (male: 13; female: 7) in the tCSA group and 28 patients in the CT group (male: 23; female: 5). The number of clear grafts 3 months postoperatively was 10 (50%) in the tCSA group and 4 (14.3%) in the CT group ( P = 0.011). The mean logarithm of the minimum angle of resolution best-corrected visual acuity was 1.49 ± 0.74 in the tCSA group and 2.10 ± 0.62 in the CT group ( P = 0.003). There were 5 patients (17.9%) with recurrence of the primary fungal infection in the CT group, 4 of whom were using topical prednisolone. There was no recurrence in the tCSA group. A logistic regression analysis revealed higher odds of a clear graft at 3 months postoperatively with topical cyclosporine 0.1% [odds ratio: 14.35 (95% confidence interval, 2.38–86.5), P = 0.004]. Conclusions: Postoperative treatment with topical cyclosporine 0.1% seems to increase graft survival and postoperative vision with reduced risk of recurrence of primary infection in eyes with fungal keratitis undergoing TPK." @default.
• W3197699016 created "2021-09-13" @default.
• W3197699016 creator A5010109659 @default.
• W3197699016 creator A5082424920 @default.
• W3197699016 date "2021-09-03" @default.
• W3197699016 modified "2023-10-18" @default.
• W3197699016 title "Use of Topical Cyclosporine 0.1% in Therapeutic Penetrating Keratoplasty for Fungal Keratitis" @default.
• W3197699016 cites W1984409867 @default.
• W3197699016 cites W1991559901 @default.
• W3197699016 cites W2003925332 @default.
• W3197699016 cites W2020928970 @default.
• W3197699016 cites W2028443422 @default.
• W3197699016 cites W2050080237 @default.
• W3197699016 cites W2069689355 @default.
• W3197699016 cites W2138157471 @default.
• W3197699016 cites W2140886686 @default.
• W3197699016 cites W2318733194 @default.
• W3197699016 cites W2330403101 @default.
• W3197699016 cites W2425135965 @default.
• W3197699016 cites W2921519840 @default.
• W3197699016 cites W2954439422 @default.
• W3197699016 cites W2975790774 @default.
• W3197699016 cites W2976332420 @default.
• W3197699016 cites W2980590987 @default.
• W3197699016 cites W2990262373 @default.
• W3197699016 cites W3041548634 @default.
• W3197699016 cites W4237275920 @default.
• W3197699016 cites W4317676130 @default.
• W3197699016 doi "https://doi.org/10.1097/ico.0000000000002827" @default.
• W3197699016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34483271" @default.
• W3197699016 hasPublicationYear "2021" @default.
• W3197699016 type Work @default.
• W3197699016 sameAs 3197699016 @default.
• W3197699016 citedByCount "5" @default.
• W3197699016 countsByYear W31976990162021 @default.
• W3197699016 countsByYear W31976990162022 @default.
• W3197699016 countsByYear W31976990162023 @default.
• W3197699016 crossrefType "journal-article" @default.
• W3197699016 hasAuthorship W3197699016A5010109659 @default.
• W3197699016 hasAuthorship W3197699016A5082424920 @default.
• W3197699016 hasConcept C118487528 @default.
• W3197699016 hasConcept C126322002 @default.
• W3197699016 hasConcept C141071460 @default.
• W3197699016 hasConcept C156957248 @default.
• W3197699016 hasConcept C188816634 @default.
• W3197699016 hasConcept C2776079991 @default.
• W3197699016 hasConcept C2776715498 @default.
• W3197699016 hasConcept C2776882836 @default.
• W3197699016 hasConcept C2778257484 @default.
• W3197699016 hasConcept C44249647 @default.
• W3197699016 hasConcept C71924100 @default.
• W3197699016 hasConceptScore W3197699016C118487528 @default.
• W3197699016 hasConceptScore W3197699016C126322002 @default.
• W3197699016 hasConceptScore W3197699016C141071460 @default.
• W3197699016 hasConceptScore W3197699016C156957248 @default.
• W3197699016 hasConceptScore W3197699016C188816634 @default.
• W3197699016 hasConceptScore W3197699016C2776079991 @default.
• W3197699016 hasConceptScore W3197699016C2776715498 @default.
• W3197699016 hasConceptScore W3197699016C2776882836 @default.
• W3197699016 hasConceptScore W3197699016C2778257484 @default.
• W3197699016 hasConceptScore W3197699016C44249647 @default.
• W3197699016 hasConceptScore W3197699016C71924100 @default.
• W3197699016 hasIssue "9" @default.
• W3197699016 hasLocation W31976990161 @default.
• W3197699016 hasLocation W31976990162 @default.
• W3197699016 hasOpenAccess W3197699016 @default.
• W3197699016 hasPrimaryLocation W31976990161 @default.
• W3197699016 hasRelatedWork W1600551280 @default.
• W3197699016 hasRelatedWork W1993713370 @default.
• W3197699016 hasRelatedWork W2019959580 @default.
• W3197699016 hasRelatedWork W2050652330 @default.
• W3197699016 hasRelatedWork W2087554230 @default.
• W3197699016 hasRelatedWork W2112949206 @default.
• W3197699016 hasRelatedWork W2414912983 @default.
• W3197699016 hasRelatedWork W289173346 @default.
• W3197699016 hasRelatedWork W4236675745 @default.
• W3197699016 hasRelatedWork W4290431419 @default.
• W3197699016 hasVolume "41" @default.
• W3197699016 isParatext "false" @default.
• W3197699016 isRetracted "false" @default.
• W3197699016 magId "3197699016" @default.
• W3197699016 workType "article" @default.